Hair loss during chemotherapy is not inevitable
Hair loss is a well documented side effect of many chemotherapy drugs. Until you are faced with the possibility of losing your hair you may, or may not, have heard that chemotherapy induced hair loss could be inevitable. Some chemotherapy drugs will damage your hair cells.
Minimise Hair Loss, Comfortably and Consistently
The DigniCap® System is an effective scalp cooling system that protects cells, and ultimately your hair, by reducing the concentration of chemotherapy being delivered to your scalp area.
Keeping my hair helped me during my chemotherapy...
Keeping my hair enabled me stay positive during treatment and feel normal. It really helped me psychologically that I didn’t look physically unwell. I even managed to carry on working part time during my chemotherapy.
Questions & answers
Most patients tolerate scalp cooling – or cold cap treatment as it is more commonly known – with the DigniCap® System very well. Some experience discomfort during the cooling period. Some side effects can be a feeling of coldness, headache and light-headedness.
This discomfort is usually transient during the pre-drug cooling phase and in the vast majority of cases these effects wear off as the temperature stabilizes around +5 degrees C.. The discomfort can be reduced by drinking something warm and wearing warm clothes or an extra blanket. It may help to wear warm clothes or warm your body with a blanket. Hot drinks could also be appropriated. View video of patients’ testimonials and see what they have to say.
The scalp cooling device is operated by the hospital personnel and will be used at each cycle on the day of chemotherapy administration. The treatment period typically commences approximately 30 minutes before chemotherapy and must continue for a set period after the conclusion of treatment depending on the chemotherapy drug and dose.
No. Scalp cooling is effective with most chemotherapy drugs, but not all. Your clinicians can tell you if scalp cooling is compatible with your treatment.
Hair loss is a well documented side effect of many chemotherapy regimes. Some chemotherapy drugs will damage your hair cells, not all. Clinical evidence shows that scalp cooling is the most effective method for the prevention of chemotherapy induced hair loss. Scalp cooling is effective with most chemotherapy drugs, but not all. For more information whether or not scalp cooling is compatible and/or successful with your treatment always consult with your clinicians.
Some chemotherapy drugs will damage your hair cells. Scalp cooling protects these cells, and ultimately your hair, by reducing the concentration of chemotherapy being delivered to your scalp area.
The DigniCap® System (a refrigerated cooling system), pumps liquid coolant through a cap that is attached to the system to lower to scalp temperature. The cold gives reduced perfusion, delivery of blood, and metabolism. The reduced blood flow gives a smaller amount of chemotherapy available for uptake in the cells and the decreased temperature results in less absorption and reduced effects of chemotherapy. These factors together reduce the risk of hair loss.
The scalp cooling treatment can reduce or completely prevent hair loss and the DigniCap® System offers you a good chance of keeping your hair during chemotherapy.
Literature shows that scalp cooling can be a viable and effective method for the prevention of chemotherapy induced hair loss, but is still dependent on factors like chemotherapy regimes, dose, infusion time, and more. Scalp cooling has been evaluated mainly on regimens including anthracyclines (such as doxorubicin and epirubicin) and taxanes (such as paclitaxel and docetaxel). It’s not always possible to know how effective the scalp cooling outcome will be until you try it. Your clinician can tell you if scalp cooling is compatible and/or successful with your treatment.
Hair loss is a well documented side effect of many chemo. Some chemotherapy drugs will damage your hair cells, not all. hemotherapy affect cells that are in the phase of division or growth. All the cells in the body are affected, as well cancer cells as healthy cells. The healthy cells are better able to recover than cancer cells, which mean that the side effects are temporary and disappear gradually when the treatment has ended.
The DigniCap® System is operated by hospital personnel and complies with international law and is registered for professional use, meaning that we are able to sell or rent to professional entities only (not private entities) and in countries where the DigniCap™ is approved by the regulatory body.
Disclaimer: The DigniCap® System is under clinical investigation in the USA and has yet to be approved by the US FDA. For the USA, this material should be considered informational only and does not constitute an offer to sell in any jurisdiction in which this product is not yet permitted to be sold in the USA. The DigniCap® System is approved for marketing in Europe. Read More About The DigniCap® System Trials